Highland Capital Management LLC Has $3.89 Million Stock Holdings in Cigna Group $CI

Highland Capital Management LLC decreased its position in Cigna Group (NYSE:CI) by 20.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,478 shares of the health services provider’s stock after selling 3,551 shares during the period. Highland Capital Management LLC’s holdings in Cigna Group were worth $3,885,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Harbor Capital Advisors Inc. increased its position in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the period. Flaharty Asset Management LLC bought a new stake in Cigna Group in the 1st quarter valued at $28,000. 1248 Management LLC acquired a new position in shares of Cigna Group in the 1st quarter valued at $29,000. Solstein Capital LLC bought a new position in shares of Cigna Group during the 2nd quarter worth about $29,000. Finally, Activest Wealth Management boosted its position in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 72 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on CI shares. TD Cowen dropped their price target on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft lowered their price objective on Cigna Group from $415.00 to $301.00 and set a “buy” rating on the stock in a research note on Monday, November 3rd. Wolfe Research cut their target price on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Sanford C. Bernstein lowered their price target on Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research report on Wednesday, November 12th. Finally, The Goldman Sachs Group cut their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a report on Tuesday, November 4th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $331.83.

Cigna Group Trading Up 0.4%

CI stock opened at $274.86 on Friday. The business has a fifty day moving average price of $275.72 and a 200 day moving average price of $291.80. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The stock has a market capitalization of $73.42 billion, a price-to-earnings ratio of 12.12, a P/E/G ratio of 1.00 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Thursday, December 4th were issued a $1.51 dividend. The ex-dividend date was Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO David Cordani bought 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The stock was acquired at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the purchase, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.70% of the stock is owned by company insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.